Verona Pharma PLC (VRNA)
39.69
+0.88
(+2.27%)
USD |
NASDAQ |
Nov 25, 16:00
39.69
0.00 (0.00%)
After-Hours: 16:00
Verona Pharma Total Assets (Quarterly): 381.82M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 381.82M |
| June 30, 2024 | 434.12M |
| March 31, 2024 | 289.91M |
| December 31, 2023 | 308.12M |
| September 30, 2023 | 292.47M |
| June 30, 2023 | 303.93M |
| March 31, 2023 | 323.15M |
| December 31, 2022 | 259.47M |
| September 30, 2022 | 274.87M |
| June 30, 2022 | 154.86M |
| March 31, 2022 | 169.32M |
| December 31, 2021 | 186.59M |
| September 30, 2021 | 201.56M |
| June 30, 2021 | 218.50M |
| March 31, 2021 | 190.15M |
| December 31, 2020 | 204.21M |
| September 30, 2020 | 245.83M |
| June 30, 2020 | 64.34M |
| March 31, 2020 | 44.36M |
| December 31, 2019 | 56.23M |
| September 30, 2019 | 67.05M |
| June 30, 2019 | 76.91M |
| March 31, 2019 | 85.04M |
| December 31, 2018 | 94.84M |
| September 30, 2018 | 99.89M |
| Date | Value |
|---|---|
| June 30, 2018 | 105.44M |
| March 31, 2018 | 116.27M |
| December 31, 2017 | 120.96M |
| September 30, 2017 | 127.14M |
| June 30, 2017 | 133.00M |
| December 31, 2016 | 56.93M |
| June 30, 2016 | 7.250M |
| June 30, 2016 | 7.250M |
| December 31, 2015 | 11.62M |
| June 30, 2015 | 15.33M |
| June 30, 2015 | 15.33M |
| December 31, 2014 | 20.43M |
| June 30, 2014 | 24.29M |
| June 30, 2014 | 24.29M |
| December 31, 2013 | 4.217M |
| June 30, 2013 | 4.259M |
| June 30, 2013 | 4.259M |
| December 31, 2012 | 4.529M |
| June 30, 2012 | 6.493M |
| June 30, 2012 | 6.493M |
| December 31, 2011 | 6.531M |
| June 30, 2011 | 4.701M |
| December 31, 2010 | 5.644M |
| June 30, 2010 | 6.862M |
| December 31, 2009 | 7.712M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
44.36M
Minimum
Mar 2020
434.12M
Maximum
Jun 2024
230.19M
Average
232.16M
Median
Total Assets (Quarterly) Benchmarks
| TC BioPharm (Holdings) PLC | 9.171M |
| Adaptimmune Therapeutics PLC | 317.44M |
| Biodexa Pharmaceuticals PLC | 17.67M |
| NuCana PLC | 25.38M |
| Autolus Therapeutics PLC | 827.49M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 251.33M |
| Shareholders Equity (Quarterly) | 130.49M |
| Debt to Equity Ratio | 0.9197 |
| Current Ratio | 13.03 |
| Net Debt Paydown Yield | -0.85% |